A Win For Minerva Neurosciences, Inc.

Mon, Aug 22, 2022 at 06:55 PM
A Win For Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. (NERV:NASDAQ) rocketted at $4.59, representing a gain of 47.8%. On Mon, Aug 22, 2022, NERV:NASDAQ touched a New 2-Week High of $4.59. The stock got featured on our News Catalysts scanner on Mon, Aug 22, 2022 at 08:32 AM in the 'BIOTECH' category. From Mon, Aug 08, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Thu, Aug 04, 2022 at $7.15 with a volume of 37M+.

About Minerva Neurosciences, Inc. (NERV:NASDAQ)

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.